Physician profile
Scott Blackburn
NPI 1770747081
$10,711.76
in general payments reported to CMS, 2019-2025
39 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $929 · 2021: $5,880 · 2022: $315 · 2023: $677 · 2024: $484 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602 · Education: $750 · Travel and Lodging: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.22 |
| Education | $750.00 |
| Travel and Lodging | $192.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,964.48 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $955.75 | 2021 | |
| Ethicon US, LLC | $804.13 | 2019-2025 | Echelon; Endopath, Linx Reflux Management System, Vistaseal |
| Zimmer Biomet Holdings, INC. | $682.21 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $500.07 | 2020-2024 | Gattex |
| Philips North America LLC | $300.00 | 2019 | |
| Davol INC. | $290.74 | 2020-2024 | Phasix Mesh |
| Shire North American Group INC | $138.68 | 2019 | |
| Tela Bio, INC. | $98.01 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Asensus Surgical, INC. | $75.76 | 2021-2024 | Senhance |
| Covidien LP | $70.30 | 2019-2020 | |
| Medtronic, INC. | $60.35 | 2022-2024 | Absorbatack |
| Baxter Healthcare | $56.99 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $53.29 | 2023-2024 | |
| Mallinckrodt Enterprises LLC | $43.64 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $41.43 | 2022-2023 | Exparel |
| Merit Medical Systems INC | $40.42 | 2021 | |
| Teleflex LLC | $38.62 | 2021-2024 | Titan Sgs |
| Mallinckrodt Hospital Products INC. | $35.56 | 2020-2021 | |
| Hologic Sales and Service, LLC | $34.46 | 2024 | Localizer |
| Biocomposites INC | $33.57 | 2025 | Stimulan |
| Cardinal Health 414 LLC | $29.02 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Hologic INC | $28.88 | 2022 | |
| Merck Sharp & Dohme LLC | $28.84 | 2019-2020 | |
| Kerecis Limited | $28.69 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Innovation Technologies INC | $26.77 | 2025 | Irrisept |
| Abbvie INC. | $24.75 | 2024 | |
| Abiomed | $22.92 | 2023 | Impella |
| Solventum Corporation | $22.70 | 2024 | Prevena |
| Integra Lifesciences Corporation | $22.50 | 2022 | |
| Bard Peripheral Vascular, INC. | $22.46 | 2021 | |
| Csl Behring | $21.97 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $18.99 | 2019 | |
| Standard Bariatrics, INC. | $17.72 | 2022 | |
| Smith+Nephew, INC. | $17.13 | 2023 | Pico 7, Renasys Go V2 Home, Renasys Touch |
| Conmed Corporation | $16.85 | 2025 | Airseal |
| Boston Scientific Corporation | $16.69 | 2023 | Spyscope Ds |
| Innocoll Pharmaceuticals Limited | $14.22 | 2021 | |
| Baudax Bio INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Blackburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.